Clinical Trial

A Phase 2 Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of HRS-7085 Tablets in Patients With Inflammatory Bowel Disease

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study is a randomized, double-blind, placebo-controlled Phase II clinical trial comprising screening period, treatment period, and follow-up period. This phase 2 study is being conducted to evaluate the efficacy, safety and pharmacokinetics of HRS-7085 in patients with moderate to severe active ulcerative colitis.
Protocol Amendment History 1 change
notable Enrollment reduced: 66 -> 48 participants 2026-06-03
Trial Details
NCT Number NCT07229950
Lead Sponsor Shandong Suncadia Medicine Co., Ltd.
Conditions Adult Patients With Moderately to Severely Active Ulcerative Colitis
Enrollment 48 participants
Start Date 2025-10-17
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-02